The Emerging Landscape of Urological Cancers: Proven Concepts, Novel Insights
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 94
Special Issue Editors
Interests: renal; testicular; bladder cancer
Interests: prostate
Special Issue Information
Dear Colleagues,
Uro-Oncology continues to be one of the most exciting fields in all of medicine. With more than 2 million new diagnoses per year and an expected continued surge over the next decade, especially in developing countries, we will face a magnitude of challenges in diagnostics, therapies and prevention.
Organ-confined, urological cancers can be treated by local treatments like (minimally-invasive) surgery or radiation with all their potential side-effects. Once spread, prognosis of most urological cancer entities remains poor. However, the treatment landscape is rapidly changing and we are continuously learning to integrate different treatment options for a more tailored and personalized approach for our patients. This Special Issue aims to 1. give an overview of recent treatment developments in urological cancer therapies, including innovative operative techniques as well as novel systemic approaches using immuno-, chemo- and other targeted or radioligand therapies and 2. provide the opportunity to display cutting-edge and thought-provoking concepts in this challenging setting.
In this Special Issue, original research articles and reviews on kidney, urothelial, prostate, penile and testicular cancer are welcome. We very much look forward to receiving your contributions.
Dr. Christian P. Meyer
Dr. Raisa S. Pompe
Dr. Quoc-Dien Trinh
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- urological cancer
- genito-urinary cancer
- novel therapies
- prostate cancer
- kidney cancer
- bladder cancer
- penile cancer
- testicular cancer
